<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VET</journal-id>
<journal-id journal-id-type="hwp">spvet</journal-id>
<journal-id journal-id-type="nlm-ta">Vet Pathol</journal-id>
<journal-title>Veterinary Pathology</journal-title>
<issn pub-type="ppub">0300-9858</issn>
<issn pub-type="epub">1544-4221</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300985811419532</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300985811419532</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Laboratory Animals</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sclerosing Cholangitis in Baboons (<italic>Papio</italic> spp) Resembling Primary Sclerosing Cholangitis of Humans</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Arenas-Gamboa</surname>
<given-names>A. M.</given-names>
</name>
<xref ref-type="aff" rid="aff1-0300985811419532">1</xref>
<xref ref-type="corresp" rid="corresp1-0300985811419532"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bearss</surname>
<given-names>J. J.</given-names>
</name>
<xref ref-type="aff" rid="aff2-0300985811419532">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hubbard</surname>
<given-names>G. B.</given-names>
</name>
<xref ref-type="aff" rid="aff3-0300985811419532">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Porter</surname>
<given-names>B. F.</given-names>
</name>
<xref ref-type="aff" rid="aff1-0300985811419532">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Owston</surname>
<given-names>M. A.</given-names>
</name>
<xref ref-type="aff" rid="aff3-0300985811419532">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jr</surname>
<given-names>E. J. Dick</given-names>
</name>
<xref ref-type="aff" rid="aff3-0300985811419532">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0300985811419532"><label>1</label>Department of Veterinary Pathobiology, Texas A&amp;M University, College of Veterinary Medicine and Biomedical Sciences, College Station, Texas</aff>
<aff id="aff2-0300985811419532"><label>2</label>Department of Defense, Armed Forces Institute of Pathology, Washington, DC</aff>
<aff id="aff3-0300985811419532"><label>3</label>Southwest National Primate Research Center at the Texas Biomedical Research Institute, San Antonio, Texas</aff>
<author-notes>
<corresp id="corresp1-0300985811419532">Angela Arenas-Gamboa, 4467-TAMU VMS Building 215, College Station, TX 77845 Email: <email>aarenas@cvm.tamu.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>49</volume>
<issue>3</issue>
<fpage>524</fpage>
<lpage>527</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American College of Veterinary Pathologists</copyright-holder>
</permissions>
<abstract>
<p>Primary sclerosing cholangitis is a chronic and progressive cholestatic liver disease that has been extensively documented in the human literature. Although it shares many features in common with chronic lymphocytic cholangitis in cats, primary sclerosing cholangitis has never been reported in a nonhuman primate. Primary sclerosing cholangitis is characterized by the presence of intrahepatic and/or extrahepatic inflammation and concentric fibrosis of bile ducts, eventually leading to cirrhosis and hepatic failure. The pathogenesis and cause remain unknown, but the disease likely involves a multifactorial mechanism with genetic- and immune-mediated components. The authors report 2 cases that histologically resemble the condition in humans; they consist of 2 adult male baboons with a clinical history of chronic elevated liver enzymes. In both cases, the liver was histologically characterized by thick bands of fibrosis and mild lymphoplasmacytic periportal cholangiohepatitis with concentric periductal fibrosis, resulting in atrophy and loss of bile ducts. Immunohistochemical analysis revealed positivity of hepatocytes to cytokeratin 7. Masson stain demonstrated marked biliary fibrosis. This is the first report that resembles sclerosing cholangitis in a nonhuman primate, and it suggests that the baboon may provide a useful animal model for this condition in humans.</p>
</abstract>
<kwd-group>
<kwd>sclerosing</kwd>
<kwd>cholangitis</kwd>
<kwd>baboons</kwd>
<kwd>liver</kwd>
<kwd>cholestasis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Two intact male Baboons in adequate body condition were part of the nonhuman primate colony at the Southwest National Primate Research Center at the Texas Biomedical Research Institute. Both animals were captive bred. Case 1 was an 11-year-old that had been part of a study group related to diet and imaging analysis. The baboon had a 2-year history of elevated liver enzymes (alanine aminotransferase, alkaline phosphatase; <xref ref-type="table" rid="table1-0300985811419532">Table 1</xref>) and a 1-month history of severe hepatomegaly and splenomegaly. At the time of necropsy, liver enzymes were markedly elevated. The baboon was also hypercholesterolemic and had a prolonged PPT time. Case 2 was a 6-year-old with a 3-year history of colitis and elevated liver enzymes (alanine aminotransferase, alkaline phosphatase, γ-glutamyltransferase); a moderate (conjugated) hyperbilirubinemia was present at the time of euthanasia. The baboon had no history of any experimental procedures performed. At necropsy, both livers were firm and contained multifocal nodular areas (<xref ref-type="fig" rid="fig1-0300985811419532">Fig. 1</xref>). On cut section, prominent bile ducts surrounded by abundant fibrous connective tissue were evident (<xref ref-type="fig" rid="fig1-0300985811419532">Fig. 2</xref>). In case 1, the distal half of the gallbladder and all associated draining ducts with extension into the liver were markedly thickened and partially obstructed. In case 2, the caudate and quadrate lobes and the gallbladder contained thickened fibrotic biliary tracts.</p>
<fig id="fig1-0300985811419532" position="float">
<label>Figure 1.</label>
<caption>
<p>Liver; case 2. Grossly, the liver is firm with multifocal nodular areas. <bold>Figure 2.</bold> Liver; case 2. On cut section, prominent bile ducts are surrounded by abundant fibrous connective tissue. <bold>Figure 3.</bold> Liver; case 1. Histologically, concentric bands of fibrosis are evident. A lymphoplasmacytic infiltrate surrounds bile ducts. Bile ducts occasionally contain a lymphoplasmacytic infiltrate. HE <bold>Figure 4.</bold> Liver; case 1. Larger bile ducts contain submucosal lymphoplasmacytic infiltrates. HE. <bold>Figure 5.</bold> Liver; case 2. Immunohistochemically, hepatocytes (asterisk) surrounding portal areas demonstrate strong cytoplasmic expression of cytokeratin 7. Bile ducts are stained dark brown. Immunohistochemistry. <bold>Figure 6.</bold> Liver; case 2. Concentric bands of fibrosis surround bile ducts. Trichome stain.</p>
</caption>
<graphic alternate-form-of="fig1-0300985811419532" xlink:href="10.1177_0300985811419532-fig1.tif"/>
</fig>
<table-wrap id="table1-0300985811419532" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical Biochemistry in 2 Baboons Resembling Primary Sclerosing Cholangitis<sup><xref ref-type="table-fn" rid="table-fn1-0300985811419532">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table1-0300985811419532" xlink:href="10.1177_0300985811419532-table1.tif"/>
<table>
<thead>
<tr>
<th> </th>
<th>
</th>
<th colspan="3">Case 1</th>
<th colspan="4">Case 2</th>
</tr>
<tr>
<th> </th>
<th>Reference Values</th>
<th>9 y</th>
<th>11 y: Jan 2009</th>
<th>11 y: Feb 2009</th>
<th>4 y: Sep 2001</th>
<th>4 y: Dec 2001</th>
<th>6.5 y: Jan 2004</th>
<th>6.5 y: Feb 2004</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALT</td>
<td>29–69 U/L</td>
<td>172</td>
<td>202</td>
<td>366</td>
<td>146</td>
<td>149</td>
<td>253</td>
<td>245</td>
</tr>
<tr>
<td>AST</td>
<td>22–62 U/L</td>
<td>52</td>
<td>69</td>
<td>186</td>
<td>35</td>
<td>55</td>
<td>61</td>
<td>41</td>
</tr>
<tr>
<td>ALP</td>
<td>0–555 U/L</td>
<td>931</td>
<td>2828</td>
<td>3019</td>
<td>1010</td>
<td>788</td>
<td>1249</td>
<td>875</td>
</tr>
<tr>
<td>GGT</td>
<td>23–63 U/L</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td>311</td>
<td>347</td>
</tr>
<tr>
<td>Bilirubin–total</td>
<td>0–0.4 mg/DL</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td>1</td>
<td align="center">0.8</td>
</tr>
<tr>
<td>Bilirubin–direct</td>
<td>0–0.2 mg/DL</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">0.5</td>
<td align="center">0.3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300985811419532">
<p>
<sup>a</sup>ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, γ-glutamyltransferase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Samples of the livers were fixed in 10% neutral buffered formalin, processed conventionally, embedded in paraffin, cut at 5 μm, stained with hematoxylin and eosin, and reviewed by light microscopy. Unstained sections from both cases were cut at 5 μm, deparaffinized, immunostained for cytokeratin 7 antigen (Dako, Denmark), and stained with Masson trichrome, silver stain, Rhodanine, Victoria blue, and Hall method for bilirubin.</p>
<p>Histologic examination of the liver in both cases revealed expansion of the portal tracts by fibrosis, a moderate increase in numbers of bile ducts, and an inflammatory infiltrate composed primarily of lymphocytes. Concentric bands of fibrosis surrounding bile ducts were observed (<xref ref-type="fig" rid="fig1-0300985811419532">Fig. 3</xref>). Larger bile ducts contained lymphoplasmacytic infiltrates in the lamina propria and a small number of intraepithelial lymphocytes along with marked biliary hyperplasia (<xref ref-type="fig" rid="fig1-0300985811419532">Fig. 4</xref>). Hepatocytes stained positively with cytokeratin 7, consistent with chronic cholestasis (<xref ref-type="fig" rid="fig1-0300985811419532">Fig. 5</xref>).<sup>
<xref ref-type="bibr" rid="bibr15-0300985811419532">15</xref>
</sup> Masson trichrome staining confirmed the marked biliary fibrosis (<xref ref-type="fig" rid="fig1-0300985811419532">Fig. 6</xref>). Rhodanine and Victoria blue stains did not reveal copper, and the Hall method did not reveal bilirubin, suggesting that copper storage and bile stasis were not responsible for the lesions observed. Based on the gross and histologic appearance, special stain results, immunohistochemical analysis, and lack of an identified cause, the lesions resemble the condition in humans referred to as primary sclerosing cholangitis (PSC).</p>
<sec id="section1-0300985811419532">
<title>Discussion</title>
<p>PSC is a well-recognized disease in humans, histologically characterized by the presence of intrahepatic and/or extrahepatic biliary duct obliterative fibrosis that eventually progresses to cirrhosis and liver failure.<sup>
<xref ref-type="bibr" rid="bibr9-0300985811419532">9</xref>,<xref ref-type="bibr" rid="bibr10-0300985811419532">10</xref>
</sup> The diagnosis is made by the exclusion of secondary causes, as the disease has no specific clinical, biochemical, or histologic findings. The term <italic>secondary sclerosing cholangitis</italic> is used for a condition with similar clinical features to PSC but in which a direct cause for the process is known.<sup>
<xref ref-type="bibr" rid="bibr8-0300985811419532">8</xref>
</sup> PSC is believed to have a multifactorial cause.<sup>
<xref ref-type="bibr" rid="bibr4-0300985811419532">4</xref>,<xref ref-type="bibr" rid="bibr11-0300985811419532">11</xref>
</sup> The disease appears to involve genetic factors, inadequate activation of the immune system, and a deleterious effect of bile acids on hepatocytes that leads to extensive fibrosis.<sup>
<xref ref-type="bibr" rid="bibr4-0300985811419532">4</xref>,<xref ref-type="bibr" rid="bibr7-0300985811419532">7</xref>,<xref ref-type="bibr" rid="bibr16-0300985811419532">16</xref>
</sup>
</p>
<p>The existence of a predisposition of PSC among relatives reflects the hereditary component of the condition. Genetic factors clearly play an important role in the disease. Siblings of PSC patients are more likely than the overall population to develop the disease.<sup>
<xref ref-type="bibr" rid="bibr2-0300985811419532">2</xref>
</sup> According to breeding colony records, the baboons in these cases were not related. Additionally, PSC manifests more commonly in males than females, with up to a 50% increased incidence.<sup>
<xref ref-type="bibr" rid="bibr1-0300985811419532">1</xref>
</sup> Interestingly, the 2 cases reported here were both males, suggesting a similar predisposition, although an increased number of cases are warranted to corroborate this finding. Immunogenetic studies have demonstrated an association between the human leukocyte antigen complex and PSC.<sup>
<xref ref-type="bibr" rid="bibr6-0300985811419532">6</xref>,<xref ref-type="bibr" rid="bibr17-0300985811419532">17</xref>
</sup> Studies regarding this area remain to be elucidated in animals.</p>
<p>PSC is strongly associated with inflammatory bowel disease. Seventy-five to ninety percent of patients with PSC have a history of coexistent ulcerative colitis or Crohn disease.<sup>
<xref ref-type="bibr" rid="bibr1-0300985811419532">1</xref>
</sup> It has been postulated that inflammatory cells are activated in the bowel of inflammatory bowel disease patients and then recruited to extraintestinal sites due to aberrant expression of the adhesion molecules MAdCAM 1 and CCL25 by the liver.<sup>
<xref ref-type="bibr" rid="bibr8-0300985811419532">8</xref>,<xref ref-type="bibr" rid="bibr11-0300985811419532">11</xref>
</sup> Bacteria that enter the portal circulation through an inflamed and highly permeable intestine could activate the innate immune system and serve as an inciting event in PSC. Activation of innate immune responses could lead to bile duct loss, progressive cholestasis, and fibrosis. Interestingly, 1 baboon had evidence of chronic colitis, and perhaps this inflammation played a role in the development of PSC.</p>
<p>Recent studies have showed an increased prevalence of <italic>Helicobacter pylori</italic> and other nongastric <italic>Helicobacter</italic> spp. in the livers of patients with PSC; however, the significance of this is still uncertain.<sup>
<xref ref-type="bibr" rid="bibr3-0300985811419532">3</xref>,<xref ref-type="bibr" rid="bibr13-0300985811419532">13</xref>
</sup> Lymphocytic cholangitis in cats is a condition that has striking similarities to PSC.<sup>
<xref ref-type="bibr" rid="bibr14-0300985811419532">14</xref>
</sup> Interestingly, <italic>Helicobacter </italic>spp. has been recently implicated in feline lymphocytic cholangitis.<sup>
<xref ref-type="bibr" rid="bibr3-0300985811419532">3</xref>,<xref ref-type="bibr" rid="bibr5-0300985811419532">5</xref>
</sup> Further studies regarding the association of <italic>Helicobacter </italic>spp. and PSC are needed. Silver stains were performed and were negative in both cases described here (data not shown).</p>
<p>Multiple studies have elaborated on the hypothesis of “bile toxicity” in PSC.<sup>4</sup> It has been proposed that bile acids that accumulate in different areas of the liver in PSC have a deleterious effect on hepatocytes and further contribute to the development of cirrhosis. In humans, one of the major pathways involved in the detoxification of bile is by hydroxylation and conjugation, leading to renal elimination. One of the major determinants in this pathway is the expression of the <italic>SXR</italic> gene.<sup>16</sup> Patients with particular genetic variants in the <italic>SXR</italic> gene are prone to more severe disease, illustrating the effect of cholestasis on disease progression. In the cases reported here, both baboons had a 2-year history of elevated levels of alkaline phosphatase, an enzyme specific for cholestasis (3019 U/L and 1033 U/L; reference value, 0–555 U/L). Whether cholestasis is a cause or a consequence of PSC in these animals remains unknown.</p>
<p>PSC should be considered in the differential diagnosis for baboons with a chronic history of elevated liver enzymes. In humans, the diagnosis is made by the exclusion of secondary causes because there are no specific clinical, biochemical, or histologic findings. It is important to mention that in baboons, causes of secondary sclerosing cholangitis must be evaluated before a diagnosis of PSC is suspected. The most commonly described causes include parasitism, cholelithiasis, pancreatitis, and trauma.<sup>
<xref ref-type="bibr" rid="bibr12-0300985811419532">12</xref>
</sup> To our knowledge, this is the first report of a condition that shares histopathologic features of PSC of humans. Further investigations to demonstrate if the syndrome in baboons is the same as in humans are still needed.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0300985811419532">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0300985811419532">
<p>The authors received no financial support for the research, authorship, and/or publication of this article. </p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0300985811419532">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aron</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Bowlus</surname>
<given-names>CL</given-names>
</name>
</person-group>. <article-title>The immunobiology of primary sclerosing cholangitis</article-title>. <source>Semin Immunopathol</source>. <year>2009</year>;<volume>31</volume>:<fpage>383</fpage>–<lpage>397</lpage>.</citation>
</ref>
<ref id="bibr2-0300985811419532">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergquist</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Bahmanyar</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis</article-title>. <source>Clin Gastroenterol Hepatol</source>. <year>2008</year>;<volume>6</volume>:<fpage>939</fpage>–<lpage>943</lpage>.</citation>
</ref>
<ref id="bibr3-0300985811419532">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boomkens</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kusters</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Detection of <italic>Helicobacter pylori</italic> in bile of cats</article-title>. <source>FEMS Immunol Med Microbiol</source>. <year>2004</year>;<volume>42</volume>:<fpage>307</fpage>–<lpage>311</lpage>.</citation>
</ref>
<ref id="bibr4-0300985811419532">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cullen</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Etiopathogenesis of primary sclerosing cholangitis</article-title>. <source>World J Gastroenterol</source>. <year>2008</year>;<volume>14</volume>:<fpage>3350</fpage>–<lpage>3359</lpage>.</citation>
</ref>
<ref id="bibr5-0300985811419532">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greiter-Wilke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scanziani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Soldati</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Association of Helicobacter with cholangiohepatitis in cats</article-title>. <source>J Vet Intern Med</source>. <year>2006</year>;<volume>20</volume>:<fpage>822</fpage>–<lpage>827</lpage>.</citation>
</ref>
<ref id="bibr6-0300985811419532">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Boberg</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Vatn</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis</article-title>. <source>Genes Immun</source>. <year>2007</year>;<volume>8</volume>:<fpage>275</fpage>–<lpage>278</lpage>.</citation>
</ref>
<ref id="bibr7-0300985811419532">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Melum</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Genome-wide association analysis in primary sclerosing cholangitis</article-title>. <source>Gastroenterology</source>. <year>2010</year>;<volume>138</volume>:<fpage>1102</fpage>–<lpage>1111</lpage>.</citation>
</ref>
<ref id="bibr8-0300985811419532">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Schrumpf</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Boberg</surname>
<given-names>KM</given-names>
</name>
</person-group>. <article-title>Update on primary sclerosing cholangitis</article-title>. <source>Dig Liver Dis</source>. <year>2010</year>;<volume>42</volume>:<fpage>390</fpage>–<lpage>400</lpage>.</citation>
</ref>
<ref id="bibr9-0300985811419532">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>LaRusso</surname>
<given-names>NF</given-names>
</name>
</person-group>. <article-title>Ludwig J. [Primary sclerosing cholangitis]</article-title>. <source>Dtsch Med Wochenschr</source>. <year>1986</year>;<fpage>111</fpage>:<volume>1263</volume>.</citation>
</ref>
<ref id="bibr10-0300985811419532">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ludwig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>MacCarty</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>LaRusso</surname>
<given-names>NF</given-names>
</name>
<etal/>
</person-group> <article-title>Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis</article-title>. <source>Hepatology</source>. <year>1986</year>;<volume>6</volume>:<fpage>560</fpage>–<lpage>568</lpage>.</citation>
</ref>
<ref id="bibr11-0300985811419532">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maggs</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>RW</given-names>
</name>
</person-group>. <article-title>Sclerosing cholangitis</article-title>. <source>Curr Opin Gastroenterol</source>. <year>2007</year>;<volume>23</volume>:<fpage>310</fpage>–<lpage>316</lpage>.</citation>
</ref>
<ref id="bibr12-0300985811419532">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maggs</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>RW</given-names>
</name>
</person-group>. <article-title>An update on primary sclerosing cholangitis</article-title>. <source>Curr Opin Gastroenterol</source>. <year>2008</year>;<volume>24</volume>:<fpage>377</fpage>–<lpage>383</lpage>.</citation>
</ref>
<ref id="bibr13-0300985811419532">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsson</surname>
<given-names>HO</given-names>
</name>
<name>
<surname>Taneera</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Castedal</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Identification of <italic>Helicobacter pylori</italic> and other <italic>Helicobacter</italic> species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis</article-title>. <source>J Clin Microbiol</source>. <year>2000</year>;<volume>38</volume>:<fpage>1072</fpage>–<lpage>1076</lpage>.</citation>
</ref>
<ref id="bibr14-0300985811419532">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasse</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Mahaffey</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>DeNovo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cornelius</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Chronic lymphocytic cholangitis in three cats</article-title>. <source>Vet Pathol</source>. <year>1982</year>;<volume>19</volume>:<fpage>99</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr15-0300985811419532">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Eyken</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Cytokeratin immunohistochemistry in liver histopatology</article-title>. <source>Adv Clin Path</source>. <year>2000</year>;<volume>4</volume>:<fpage>201</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr16-0300985811419532">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Halilbasic</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Marschall</surname>
<given-names>HU</given-names>
</name>
<etal/>
</person-group> <article-title>CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice</article-title>. <source>Hepatology</source>. <year>2005</year>;<volume>42</volume>:<fpage>420</fpage>–<lpage>430</lpage>.</citation>
</ref>
<ref id="bibr17-0300985811419532">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiencke</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Karlsen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Boberg</surname>
<given-names>KM</given-names>
</name>
<etal/>
</person-group> <article-title>Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes</article-title>. <source>Tissue Antigens</source>. <year>2007</year>;<volume>69</volume>:<fpage>161</fpage>–<lpage>169</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>